Skip to main content

Want a detailed portfolio tracker?

Performance analysis of Relay Therapeutics (RLAY)

Annual Return

Over the past 3 years, RLAY has had an average annual return of +15.95%, underperforming the benchmark SPY, which returned +19.62% annual.

Over the past 5 years, RLAY has had an average annual return of -10.85%, underperforming the benchmark SPY, which returned +12.73% annual.

Since Jul 16, 2020, RLAY has had an average annual return of -9.44%, underperforming the benchmark SPY, which returned +16.71% annual.

2026202520242023202220212020
+128.09%+105.45%-62.59%-26.30%-51.36%-26.10%+18.57%

Monthly Return

YearJanFebMarAprMayJunJulAugSepOctNovDecAnnually Total
2026-9.49%+33.96%-3.01%+30.26%+8.41%+33.15%+3.15%+128.09%
2025+8.51%-23.69%-23.12%+27.01%-9.89%+15.30%+1.72%+1.99%+45.41%+36.80%+10.95%+6.81%+105.45%
2024-15.98%+8.34%-17.17%-21.45%-1.67%+1.69%+26.08%-17.40%+4.28%-20.40%-16.60%-12.38%-62.59%
2023+43.66%-24.74%+1.97%-30.96%-2.03%+12.74%+0.33%-18.89%-17.73%-21.51%+19.86%+39.17%-26.30%
2022-27.94%+8.95%+24.13%-20.38%-31.68%+2.88%+13.56%+20.75%-2.61%-0.66%-16.39%-19.60%-51.36%
2021+19.31%-16.76%-16.24%-8.27%+1.29%+13.91%-11.34%-1.26%-1.55%+5.45%-11.51%+4.38%-26.10%
2020+1.17%+13.33%+5.97%-13.27%+44.32%-22.04%+18.57%

Drawdown analysis of Relay Therapeutics (RLAY)

The maximum drawdown for the RLAY was -96.75%, occurring on Apr 4, 2025. This drawdown has not yet recovered.

The current RLAY drawdown is -68.64%.

Since Jul 16, 2020 RLAY has experienced the following drawdowns:

  • 50% or more: 1 time
  • 40% or more: 1 time
  • 30% or more: 2 times
  • 20% or more: 4 times
  • 10% or more: 5 times
DepthStartTo BottomBottomTo RecoverEndTotal
-96.75%Jan 22, 20211055Apr 4, 2025OngoingOngoingOngoing
-30.98%Nov 25, 202030Jan 11, 20216Jan 20, 202136
-25.40%Jul 17, 202020Aug 14, 202024Sep 18, 202044
-21.36%Oct 5, 202021Nov 3, 20206Nov 11, 202027
-15.71%Sep 21, 20205Sep 28, 20205Oct 5, 202010
-6.49%Nov 17, 20201Nov 18, 20204Nov 24, 20205
-0.17%Nov 12, 20201Nov 13, 20201Nov 16, 20202